Clinical trial
First Time in Man Trial for Friulimicin B
NCT00492271 · MerLion Pharmaceuticals GmbH, Industry · Terminated
Key facts
| NCT number | NCT00492271 |
|---|---|
| Title | First Time in Man Trial for Friulimicin B |
| Official title | A Double-Blind, Placebo-Controlled, Randomized, Dose-Escalating Study of Single (Part A) and Multiple (Part B) Intravenous Doses of Friulimicin B in Healthy Subjects |
| Lead sponsor | MerLion Pharmaceuticals GmbH, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Community Acquired Pneumonia, Staphylococcal Skin Infections |
| Intervention type | Drug |
| Interventions | Friulimicin B |
| Enrollment | 31 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 27, 2007 |
| Last update posted | Jul 23, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: